首页> 外文期刊>Colloids and Surfaces, B. Biointerfaces >Antifungal and antiprotozoal green amino acid-based rhamnolipids: Mode of action, antibiofilm efficiency and selective activity against resistant Candida spp. strains and Acanthamoeba castellanii
【24h】

Antifungal and antiprotozoal green amino acid-based rhamnolipids: Mode of action, antibiofilm efficiency and selective activity against resistant Candida spp. strains and Acanthamoeba castellanii

机译:基于抗真菌和抗双胞痘绿氨基酸的肾上腺素:作用方式,抗抗性念珠菌SPP的抗性效率和选择性活性。 菌株和acanthamoeba castellanii

获取原文
获取原文并翻译 | 示例
           

摘要

Nowadays, infections caused by fungi and protists constitute a serious problem for public health services. The limited number of treatment options coupled with the increasing number of resistant microorganisms makes necessary the development of new non-toxic antifungal and antiprotozoal agents. Cationic amino acid-based rhamnolipids have been recently prepared by our group and exhibited good antibacterial activity. In this work, the antifungal, antibiofilm and antiprotozoal activity of these new rhamnolipids was investigated against a collection of fluconazole-resistant strains of different Candida species and Acanthamoeba castellanii, respectively. The arginine-RLs exhibited good antifungal activity against all fluconazole-resistant Candida spp. strains tested at MICs ranging from 6.5 to 20.7 mg/L. Their mechanism of action involves alterations in the permeability of the cell membranes that provoke death by apoptosis. The Arginine based-RLs also disperse Candida biofilms at low concentrations, similar to the MICs. All RLs tested (anionic and cationic) showed antiprotozoal activity, the arginine derivatives had the best activity killing the Acanthamoeba castellanii at concentrations of 4 mg/L. Interestingly, these surfactants have a wide range of action against yeast and A. castellanii in which they do not show toxicity against keratinocytes and fibroblasts. These results indicate that these new rhamnolipids have a sufficiently wide safety margin to be considered good candidates for several pharmaceutical applications such as combating fungal resistance and microbial biofilms and the formulation of antiprotozoal drugs.
机译:如今,真菌和保护者引起的感染构成了公共卫生服务的严重问题。与越来越多的抗性微生物相结合的有限的治疗方法使得新的无毒抗真菌剂和抗双胞嘧啶剂的开发是必要的。阳离子氨基酸的耳鼻脂已被我们的基团制备,并表现出良好的抗菌活性。在这项工作中,研究了这些新的耳蜗的抗真菌,抗血糖和抗丙氨酸活性分别研究了不同念珠菌种类和Acanthamoeba Castellanii的氟康唑抗性菌株的集合。精氨酸-RLS对所有氟康唑抗性念珠菌SPP表现出良好的抗真菌活性。在MICS中测试的菌株在6.5至20.7mg / L的范围内。它们的作用机制涉及细胞膜渗透性渗透性的改变,促使细胞凋亡。精氨酸基RLS还在低浓度下分散念珠菌生物膜,类似于麦克风。所有RLS测试(阴离子和阳离子)显示出抗丙酮活性,精氨酸衍生物具有杀死4mg / L的浓度的最佳活性。有趣的是,这些表面活性剂对酵母和A. Castellanii的各种作用有它们,它们不会对角蛋白细胞和成纤维细胞显示出毒性。这些结果表明,这些新的耳蜗具有足够宽的安全裕度,以便被认为是几种药物应用的良好候选者,例如对抗真菌抗性和微生物生物膜以及抗丙二醇的制剂。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号